4/7
09:05 am
acad
Acadia Pharmaceuticals Announces DAYBUE® STIX (trofinetide) is Now Broadly Available in the United States for the Treatment of Rett Syndrome
Low
Report
Acadia Pharmaceuticals Announces DAYBUE® STIX (trofinetide) is Now Broadly Available in the United States for the Treatment of Rett Syndrome
4/4
11:42 pm
acad
A Look At ACADIA Pharmaceuticals (ACAD) Valuation As Shares Trade Near Recent Levels [Yahoo! Finance]
Low
Report
A Look At ACADIA Pharmaceuticals (ACAD) Valuation As Shares Trade Near Recent Levels [Yahoo! Finance]
3/25
08:38 am
acad
ACADIA Pharmaceuticals (ACAD) was upgraded by Bank of America Corporation from "neutral" to "buy". They now have a $29.00 price target on the stock.
Low
Report
ACADIA Pharmaceuticals (ACAD) was upgraded by Bank of America Corporation from "neutral" to "buy". They now have a $29.00 price target on the stock.
3/18
09:47 am
acad
Condor Software Raises $24 Million Series A Funding to Build the First Financial Intelligence Platform for Life Sciences [Yahoo! Finance]
Low
Report
Condor Software Raises $24 Million Series A Funding to Build the First Financial Intelligence Platform for Life Sciences [Yahoo! Finance]
3/17
02:27 pm
acad
ACADIA Pharmaceuticals Maps Key CNS Readouts: Remlifanserin ADP Data Due Aug–Oct, ACP-211 Next Year [Yahoo! Finance]
Low
Report
ACADIA Pharmaceuticals Maps Key CNS Readouts: Remlifanserin ADP Data Due Aug–Oct, ACP-211 Next Year [Yahoo! Finance]
3/15
09:34 pm
acad
Assessing ACADIA Pharmaceuticals (ACAD) Valuation After Recent Share Price Weakness [Yahoo! Finance]
Medium
Report
Assessing ACADIA Pharmaceuticals (ACAD) Valuation After Recent Share Price Weakness [Yahoo! Finance]
3/12
04:20 pm
acad
Acadia Pharmaceuticals to Participate in the Stifel 2026 Virtual CNS Forum [Yahoo! Finance]
Medium
Report
Acadia Pharmaceuticals to Participate in the Stifel 2026 Virtual CNS Forum [Yahoo! Finance]
3/12
04:05 pm
acad
Acadia Pharmaceuticals to Participate in the Stifel 2026 Virtual CNS Forum
Medium
Report
Acadia Pharmaceuticals to Participate in the Stifel 2026 Virtual CNS Forum
3/11
03:15 pm
acad
ACADIA Pharmaceuticals Showcases $1B+ Net Sales, $800M Cash, and Key Alzheimer's Readout Ahead [Yahoo! Finance]
Low
Report
ACADIA Pharmaceuticals Showcases $1B+ Net Sales, $800M Cash, and Key Alzheimer's Readout Ahead [Yahoo! Finance]
3/5
12:24 am
acad
Acadia Faces EU Setback On Trofinetide As Valuation Signals Diverge [Yahoo! Finance]
Medium
Report
Acadia Faces EU Setback On Trofinetide As Valuation Signals Diverge [Yahoo! Finance]
3/4
11:55 pm
acad
Is It Time To Revisit ACADIA Pharmaceuticals (ACAD) After Recent Share Price Weakness? [Yahoo! Finance]
Medium
Report
Is It Time To Revisit ACADIA Pharmaceuticals (ACAD) After Recent Share Price Weakness? [Yahoo! Finance]
3/4
03:56 pm
acad
ACADIA Pharmaceuticals (ACAD) had its price target raised by JPMorgan Chase & Co. from $31.00 to $34.00. They now have an "overweight" rating on the stock.
Low
Report
ACADIA Pharmaceuticals (ACAD) had its price target raised by JPMorgan Chase & Co. from $31.00 to $34.00. They now have an "overweight" rating on the stock.
3/3
04:28 pm
acad
Acadia Pharmaceuticals Appoints Jonathan M. Poole to its Board of Directors [Yahoo! Finance]
Medium
Report
Acadia Pharmaceuticals Appoints Jonathan M. Poole to its Board of Directors [Yahoo! Finance]
3/3
04:05 pm
acad
Acadia Pharmaceuticals Appoints Jonathan M. Poole to its Board of Directors
Medium
Report
Acadia Pharmaceuticals Appoints Jonathan M. Poole to its Board of Directors
3/2
09:02 pm
acad
ACADIA Pharmaceuticals (ACAD) had its "neutral" rating reaffirmed by Bank of America Corporation.
Low
Report
ACADIA Pharmaceuticals (ACAD) had its "neutral" rating reaffirmed by Bank of America Corporation.
3/2
05:54 pm
acad
ACADIA Pharmaceuticals Targets $1.7B Sales by 2028, Teases Key Phase 2 Data in 2025 [Yahoo! Finance]
Low
Report
ACADIA Pharmaceuticals Targets $1.7B Sales by 2028, Teases Key Phase 2 Data in 2025 [Yahoo! Finance]
3/2
04:05 pm
acad
Acadia Pharmaceuticals Announces Plan to Request Re-Examination Following Negative CHMP Opinion for Trofinetide for the Treatment of Rett Syndrome
Low
Report
Acadia Pharmaceuticals Announces Plan to Request Re-Examination Following Negative CHMP Opinion for Trofinetide for the Treatment of Rett Syndrome
3/2
01:59 pm
acad
Wolfe Research Notes Conviction-Driven Opportunities in ACADIA Pharmaceuticals Inc.'s (ACAD) Therapeutic Domains [Yahoo! Finance]
Low
Report
Wolfe Research Notes Conviction-Driven Opportunities in ACADIA Pharmaceuticals Inc.'s (ACAD) Therapeutic Domains [Yahoo! Finance]
2/28
09:08 am
acad
Acadia Pharmaceuticals: Undervalued Despite Robust Revenues From Approved Drugs, With Pipeline Kicker [Seeking Alpha]
Medium
Report
Acadia Pharmaceuticals: Undervalued Despite Robust Revenues From Approved Drugs, With Pipeline Kicker [Seeking Alpha]
2/26
12:53 pm
acad
ACADIA Pharmaceuticals (ACAD) had its price target raised by TD Cowen from $35.00 to $37.00. They now have a "buy" rating on the stock.
Medium
Report
ACADIA Pharmaceuticals (ACAD) had its price target raised by TD Cowen from $35.00 to $37.00. They now have a "buy" rating on the stock.
2/26
10:30 am
acad
ACADIA Pharmaceuticals (ACAD) had its price target lowered by Royal Bank Of Canada from $31.00 to $30.00. They now have an "outperform" rating on the stock.
Low
Report
ACADIA Pharmaceuticals (ACAD) had its price target lowered by Royal Bank Of Canada from $31.00 to $30.00. They now have an "outperform" rating on the stock.
2/26
09:55 am
acad
ACADIA Pharmaceuticals (ACAD) had its price target raised by Citizens Jmp from $34.00 to $35.00. They now have a "market outperform" rating on the stock.
Low
Report
ACADIA Pharmaceuticals (ACAD) had its price target raised by Citizens Jmp from $34.00 to $35.00. They now have a "market outperform" rating on the stock.
2/26
09:26 am
acad
ACADIA Pharmaceuticals (ACAD) had its price target lowered by Stifel Nicolaus from $25.00 to $24.00. They now have a "hold" rating on the stock.
Low
Report
ACADIA Pharmaceuticals (ACAD) had its price target lowered by Stifel Nicolaus from $25.00 to $24.00. They now have a "hold" rating on the stock.
2/26
12:42 am
acad
ACADIA Pharmaceuticals Inc (ACAD) Q4 2025 Earnings Call Highlights: Record Revenue Growth and ... [Yahoo! Finance]
Low
Report
ACADIA Pharmaceuticals Inc (ACAD) Q4 2025 Earnings Call Highlights: Record Revenue Growth and ... [Yahoo! Finance]
2/25
06:58 pm
acad
ACADIA (ACAD) Q4 2025 Earnings Call Transcript [Yahoo! Finance]
Low
Report
ACADIA (ACAD) Q4 2025 Earnings Call Transcript [Yahoo! Finance]